Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A sterile intravenous crystalloid combination containing **dextrose monohydrate, sodium chloride, sodium lactate, and potassium chloride**. This product is essentially a potassium-containing dextrose-lactated Ringer's solution used for **parenteral replacement of extracellular fluid and electrolyte losses**, and as a source of **water, electrolytes, and minimal calories**. Its pharmacologic effect is non-receptor-mediated: sodium and chloride help restore extracellular volume and electrolyte balance, potassium chloride replenishes potassium, dextrose provides carbohydrate calories, and sodium lactate is metabolized to bicarbonate, contributing an **alkalinizing** effect. It is used clinically in adults and pediatric patients when intravenous fluid, electrolyte, and limited caloric support are required.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on dextrose monohydrate + sodium chloride + sodium lactate + potassium chloride.